Ellis Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-400
| Closed | -$3K | – | 689 |
|
|
2022
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 711 |
|
|
2022
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 714 |
|
|
2022
Q1 | $3K | Hold |
400
| – | – | ﹤0.01% | 736 |
|
|
2021
Q4 | $3K | Hold |
400
| – | – | ﹤0.01% | 735 |
|
|
2021
Q3 | $3K | Buy |
400
+53
| +15% | +$398 | ﹤0.01% | 719 |
|
|
2021
Q2 | $3K | Sell |
347
-1
| -0.3% | -$9 | ﹤0.01% | 723 |
|
|
2021
Q1 | $4K | Hold |
348
| – | – | ﹤0.01% | 688 |
|
|
2020
Q4 | $3K | Buy |
348
+1
| +0.3% | +$9 | ﹤0.01% | 672 |
|
|
2020
Q3 | $3K | Buy |
347
+100
| +40% | +$865 | ﹤0.01% | 666 |
|
|
2020
Q2 | $2K | Hold |
247
| – | – | ﹤0.01% | 675 |
|
|
2020
Q1 | $2K | Hold |
247
| – | – | ﹤0.01% | 655 |
|
|
2019
Q4 | $2K | Hold |
247
| – | – | ﹤0.01% | 647 |
|
|
2019
Q3 | $1K | Hold |
247
| – | – | ﹤0.01% | 683 |
|
|
2019
Q2 | $2K | Buy |
+247
| New | +$2K | ﹤0.01% | 623 |
|